News

Argenx, Halozyme win FDA nod for Vyvgart Hytrulo prefilled syringe
The U.S. Food and Drug Administration (FDA) has approved Dutch biotech argenx’s (NASDAQ:ARGX) (OTCPK:ARGNF) autoimmune disease drug Vyvgart Hytrulo, developed with Halozyme Therapeutics (NASDAQ:HALO), ...
Experimental drug looks to be gastric bypass surgery in pill form
One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual ...
US FDA approves syringe version of Argenx's immune disorder drug
The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...
The Mirror US on MSN3d
Florida death row inmate Michael Tanzi's directed chilling last words to murdered victim's family
The 48-year-old was convicted of first-degree murder, carjacking, kidnapping, and armed robbery. A Monroe County jury ...